ÂÜÀòÂÒÂ×

Dr Kaneko has served as a member of our board of directors since May 2015. Dr Kaneko has been a managing director at Skyline Venture Partners, a venture capital firm, since 1999. Previously, Dr Kaneko served on the board of LeukoSite, a biopharmaceutical company, until its merger with Millennium Pharmaceuticals in 1999. Dr Kaneko also served as CFO and Vice President, Business Development at Tularik, a biopharmaceutical company, from 1992 until 1998. Dr Kaneko served as a Senior Vice President and CFO of Ionis Pharmaceuticals, a biopharmaceutical company, which went public in May 1991 during his tenure. Dr Kaneko began his career at Genentech, where he served in a business development role, a biotechnology company, and as head of corporate finance in the investment banking division of Paribas Capital Markets LTD in Tokyo.

Dr Kaneko received an undergraduate degree and an MD degree from Keio University in Tokyo, and an MBA from Stanford Business School. He currently serves as a member of the Dean of Research Advisory Council at Stanford University.